文章基本信息

标题：Author Correction: Combining DNMT and HDAC6 inhibitors increases anti-tumor immune signaling and decreases tumor burden in ovarian cancer
本地全文：下载
作者：Sara Moufarrij ; Aneil Srivastava ; Stephanie Gomez 等
期刊名称：Scientific Reports
电子版ISSN：2045-2322
出版年度：2021
卷号：11
DOI：10.1038/s41598-021-04066-1
语种：English
出版社：Springer Nature
摘要：Correction to: Scientific reports 10.1038/s41598-020-60409-4, published online 26 February 2020 Noor Diab was omitted from the author list in the original version of this Article. The Author Contributions section now reads: S.M., A.S., M.L.-A., A.V., and K.B.C. designed the experiments. S.M., A.S., S.G., M.H., P.T.A., S.C., E.P., K.R., N.D., and A.Y. performed experiments. J.L. and W.Z. provided cisplatin-resistant cell lines IGROV-1 CR and SKOV3 CR. S.M., A.S., S.G., A.V., and K.B.C. wrote, edited, and revised the manuscript. The original Article and accompanying Supplementary Information file has been corrected.